Literature DB >> 438330

Regulation of hepatic transport of bile salt. Effect of protein synthesis inhibition on excretion of bile salts and their binding to liver surface membrane fractions.

M C Gonzalez, E Sutherland, F R Simon.   

Abstract

The overall transport of bile salts across the hepatocyte is characterized as a carrier-mediated process whose rate-limiting step is biliary secretion. Specific bile salt binding proteins have been identified in liver surface membrane fractions and were postulated to represent the initial interaction in bile salt translocation across both the sinusoidal and canalicular membranes. To test this hypothesis, cycloheximide was administered to rats to inhibit hepatic protein synthesis. 16 h after cycloheximide administration [14C]leucine incorporation into hepatic protein was inhibited by 93% at 1 h and 47% at 12 h. However, values of liver function tests were not increased, although serum albumin, serum alanine amino-transferase, and alkaline phosphatase were significantly decreased. Light and electron microscopy did not demonstrate necrosis or fat accumulation. The latter demonstrated minimal disorganization of rough endoplasmic reticulum and occasional lamellar whorls. 16 h after cycloheximide administration bile salt independent bile flow, basal bile salt excretion, and basal bile flow were unaltered, but the maximum bile salt transport capacity was reduced to 62% of control and 24 h later to 38%. Decreased bile salt transport was reversible, for it returned to control values after 48 h, when hepatic protein synthesis was also normal. Maximum bromosulfophthalein (BSP) transport, on the other hand, was reduced after 16 h to only 85% of control. Both bile salt and BPS maximum transport capacities decreased with time during inhibition of protein synthesis, apparently following first order kinetics. It was estimated that their half-lives are 20 h for bile salt transport and 55 h for BSP transport. These different turnover rates suggest that cycloheximide does not decrease active transport through generalized hepatic dysfunction or alteration of high energy sources possibly required for transport. The maximum number of [14C]cholic acid binding sites in liver surface membrane fractions was determined by an ultrafiltration assay. They were reduced to 68% of control after 16 h of cycloheximide and to 25% after 24 h. This reduction in the number of binding sites is apparently selective, for the activities of the liver surface membrane enzymes (Na+-K+)ATPase, Mg++-ATPase, and 5'-nucleotidase were not significantly changed. The associated alterations in bile salt transport and the maximum number of binding sites after cycloheximide administration suggests that these receptors may be the bile salt carriers.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438330      PMCID: PMC372003          DOI: 10.1172/JCI109351

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Requirement for protein synthesis in the regulation of protein breakdown in cultured hepatoma cells.

Authors:  D Epstein; S Elias-Bishko; A Hershko
Journal:  Biochemistry       Date:  1975-11-18       Impact factor: 3.162

2.  Neutral amino acid transport in surface membrane vesicles isolated from mouse fibroblasts: intrinsic and extrinsic models of regulation.

Authors:  J E Lever
Journal:  J Supramol Struct       Date:  1977

3.  Uptake of taurocholic acid into isolated rat-liver cells.

Authors:  L R Schwarz; R Burr; M Schwenk; E Pfaff; H Greim
Journal:  Eur J Biochem       Date:  1975-07-15

4.  Identification and characterization of a bile acid receptor in isolated liver surface membranes.

Authors:  L Accatino; F R Simon
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

5.  Studies of the beta-galactoside transporter in inverted membrane vesicles of Escherichia coli. I. Symmetrical facilitated diffusion and proton gradient-coupled transport.

Authors:  J R Lancaster; P C Hinkle
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

Review 6.  The gradient hypothesis and other models of carrier-mediated active transport.

Authors:  R K Crane
Journal:  Rev Physiol Biochem Pharmacol       Date:  1977       Impact factor: 5.545

7.  Isolation of an organ specific protein antigen from cell-surface membrane of rat liver.

Authors:  D M Neville
Journal:  Biochim Biophys Acta       Date:  1968-04-09

8.  Stimulation of hepatic sodium and potassium-activated adenosine triphosphatase activity by phenobarbital. Its possible role in regulation of bile flow.

Authors:  F R Simon; E Sutherland; L Accatino
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  Bile acid-induced increase in bile acid-independent flow and plasma membrane NaK-ATPase activity in rat liver.

Authors:  R J Wannagat; R D Adler; R K Ockner
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

10.  Investigations on the sodium dependence of bile acid fluxes in the isolated perfused rat liver.

Authors:  A Dietmaier; R Gasser; J Graf; M Peterlik
Journal:  Biochim Biophys Acta       Date:  1976-08-04
View more
  4 in total

1.  Regulation of bile salt transport in rat liver. Evidence that increased maximum bile salt secretory capacity is due to increased cholic acid receptors.

Authors:  F R Simon; E M Sutherland; M Gonzalez
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

Review 2.  Supra-molecular association and polymorphic behaviour in systems containing bile acid salts.

Authors:  Marco Calabresi; Patrizia Andreozzi; Camillo La Mesa
Journal:  Molecules       Date:  2007-08-07       Impact factor: 4.411

3.  Reversal of ethinyl estradiol-induced bile secretory failure with Triton WR-1339.

Authors:  F R Simon; M Gonzalez; E Sutherland; L Accatino; R A Davis
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

4.  Control of biliary phospholipid secretion. Effect of continuous and discontinuous infusion of taurocholate on biliary phospholipid secretion.

Authors:  K Rahman; T G Hammond; P J Lowe; S G Barnwell; B Clark; R Coleman
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.